MedPath

A clinical trial to study the effects of two drugs Medohar Guggulu and Weight Go in patients with obesity.

Phase 2
Conditions
Health Condition 1: E669- Obesity, unspecified
Registration Number
CTRI/2023/10/058244
Lead Sponsor
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Inclusion criteria

Patients between the age group of 18-60 years will be selected.

Patients having classical sign and symptoms of Sthaulya.

Patients of either gender will be selected.

Patients between BMI of 25-40 kg/m2 will be selected.

Exclusion Criteria

Exclusion criteria

Drug induced obesity.

Patients having serious diseases such as hepatic disease, cardiac disease, renal disease, pulmonary disease, history of thyroid , uncontrolled hypertension and Diabetes mellitus, other endocrine disorders will be excluded.

Other systemic diseases which intervenes with the course of treatment.

Patients having BMI > 40kg/m2 will be excluded.

Pregnant females and lactating women will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subjective parameters-Grading will be done considering sign and symptoms of sthaulya- <br/ ><br>1. Sphig chalatva (Pendlous movement of buttocks) <br/ ><br>2. Udara chalatva (Pendulous movement of belly) <br/ ><br>3. Stana chalatva (Pendulous movement of breast) <br/ ><br>4. Swasa kasta (Breathlessness) <br/ ><br>5. Janusandhishoola (Pain in both knee joints) <br/ ><br>6. Atinidra (Excessive sleep) <br/ ><br>7. Kshudaatimatram (Increased hunger) <br/ ><br>8. Pipasaatiyogam (Excessive thirst) <br/ ><br>9. Swedabadha (Excessive sweating) <br/ ><br>10. Daurgandhya (Foul smell from body) <br/ ><br>11. Daurbalya (Weakness) <br/ ><br>Objective parameter- <br/ ><br>1. Body weight <br/ ><br>2. Body Mass Index <br/ ><br>3. Waist-Hip ratio <br/ ><br>4. Measurement of circumference: Chest,abdomen,hip <br/ ><br> is assessedTimepoint: 0day 30days 60 days
Secondary Outcome Measures
NameTimeMethod
Objective parameter- <br/ ><br>1. Body weight <br/ ><br>2. Body Mass Index <br/ ><br>3. Waist-Hip ratio <br/ ><br>4. Measurement of circumference: Chest,abdomen,hip <br/ ><br> is assessedTimepoint: 0th day 30th day 60th day
© Copyright 2025. All Rights Reserved by MedPath